« Previous
Next »
Phytomedicine
Volume 16, Issue 2
, Pages 244-251
, March 2009
Determination and pharmacokinetic study of taxifolin in rabbit plasma by high-performance liquid chromatography
References
- In: Andersen ØM, Markham KR editor. Flavonoids: Chemistry, Biochemistry and Application. Boca Raton, FL: CRC Press; 2006;
- . Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991;175:880–885
- . Urinary metabolites of French maritime pine bark extract in humans. Pharmazie. 2000;55:364–368
- . Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radical Biol. Med. 2004;37:287–303
- . High-performance liquid chromatographic method for the determination of mangiferin, likviritin and dihydroquercetin in rat plasma and urine. J. Chromatogr. 1992;577:371–375
- . Single and multiple dose pharmacokinetics of maritime pine bark extract (pycnogenol) after oral administration to healthy volunteers. BMC Clin. Pharmacol. 2006;6:4
- ICH, Q2A, 1994. Harmonised tripartite guideline, text on validation of analytical procedures, IFPMA. In: Proceedings of the International Conference on Harmonization, Geneva, March 1994; 1.
- ICH, Q2B, 1996. Harmonised tripartite guideline, validation of analytical procedure: methodology, IFPMA. In: Proceedings of the International Conference on Harmonization, Geneva, March 1996; 1.
- . Self-microemulsifying drug delivery systems as nanosystems for bioavailability enhancement of taxifolin in vitro. Planta Med. 2007;73:905–906
- . Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005;81:230S–242S
- . Factors affecting flavonoids absorption. BioFactors. 2000;12:175–180
- . Correction of the high blood viscosity syndrome by a mixture of diquertin and ascorbic acid in vitro and in vivo. Phytother. Res. 2003;17:276–278
- . Hemorheological and antioxidant effects of ascovertin in patients with sclerosis of cerebral arteries. Clin. Hemorheol. Microcirc. 2004;30:449–452
- . Medicinal Preparations on the Base of Dihydroquerzetine. Tomsk: Publishing House of Tomsk University; 2005;
- . Clinical Pharmacokinetics. Lippincott, Williams, & Wilkins; 1995;
- . Dietary intake and bioavailability of polyphenols. J. Nutr. 2000;130:2073S–2085S
- . Self-microemulsifying drug delivery system as nanosystems for bioavailability enhancement of flavonoids in vitro. Eur. J. Pharm. Sci. 2008;34(Suppl. 1):S29
- . Nanosystems as a way of improving the bioavailability of natural compounds. Farmatsiia-Moskva. 2008;7:53–57
- . Nanosystems with taxifolin for solid dosage form and its bioavailability in vitro. Planta Med. 2007;73:905
- . Experimental pharmacokinetics of biologically active plant phenolic compounds III. Pharmacokinetics of dihydroquercetin. Phytother. Res. 1993;7:208–210
- . Absorption and metabolism of flavonoids. Free Radical Biol. Med. 2004;36:829–837
- . Unusual chemical transformations of natural flavonoids. Planta Med. 2006;72:1070
- Zherdev, V., Kolyvanov, G., Litvin, A., Sariev, A., Kolesnik, Yu., Titova, E., Tikhonov, V., Shmatkov, D., 2007. Pre-clinical pharmacokinetics of dihydroquercetin. In: Apers, S., Budantsev, A., Carrier, J., Choi, Y., Dadali, V., Hankemeier, T., van der Heijden, R., Hiltunen, R., Makarov, V., Makarova, M., Pozharitskaya, O., Samylina, I., Shikov, A., Shikh, E., Sukhanov, B., Sychev, D., Tutelyan, V., Verpoorte, R., Vladimirov, Yu., Witkamp, R., Yakovlev, G., Zenkevich, I., (Eds.), Abstracts Book of Phytopharm 2007. p. 76.
PII: S0944-7113(08)00188-8
doi: 10.1016/j.phymed.2008.10.002
© 2008 Elsevier GmbH. All rights reserved.
« Previous
Next »
Phytomedicine
Volume 16, Issue 2
, Pages 244-251
, March 2009
